Get started
Author

Michael Lanuti

Observed names: Lanuti Michael, Lanuti, Michael
OpenAlex ID: A5005166017
The 2026 American Association for Thoracic Surgery Expert Consensus Document: Evaluation and management of N2+ non–small cell lung cancer
2026 · Philip A. Linden, Linda W. Martin, et al. · Journal of Thoracic and Cardiovascular Surgery · 3
PDF
Resection outcomes according to pathologic risk in ≤2 cm invasive lung adenocarcinoma
2026 · Zhizhou Yang, Daniel X. Xiong, et al. · Journal of Thoracic and Cardiovascular Surgery · 1
Deep learning model for pathological invasiveness prediction using smartphone-based surgical resection images in clinical stage IA lung adenocarcinoma (SuRImage): a prospective, multicentric, diagnostic study
2026 · Lintong Yao, Linghan Cai, et al. · The Lancet Digital Health · 1
The implementation of a mobile application and web-based platform for peri-operative patient-tailored education and tracking of patient-reported outcomes after esophagectomy
2025 · Paolo de Angelis, Eliza Hompe, et al. · Diseases of the Esophagus · 1
Epigenetic age acceleration enhances prediction of overall survival in early-stage non-small cell lung cancer
2026 · Isabella Gandara, Mulong Du, et al. · iScience
Defining Effective Margin Distances to Minimize Locoregional Recurrence After Sublobar Resection for ≤2 cm Invasive Lung Adenocarcinoma
2026 · Zhizhou Yang, Erin Y. Yuan, et al. · JTO Clinical and Research Reports
Mesothelioma: Pleural, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology
2026 · James Stevenson, Gregory J. Riely, et al. · Journal of the National Comprehensive Cancer Network
Incidental use of angiotensin system inhibitors during neoadjuvant therapy for esophageal adenocarcinoma: an analysis of survival
2026 · Michael Lanuti · Translational Cancer Research
A novel wearables-based sleep quality index to quantify postoperative sleep quality
2026 · Zhengyu Fang, Danny Wang, et al. · Journal of Thoracic and Cardiovascular Surgery
Transitioning from neoadjuvant chemoradiation to perioperative chemotherapy for esophageal adenocarcinoma: Impact on margins and pathologic outcomes
2026 · Paolo de Angelis, Seif Elmankabadi, et al. · JTCVS Open
PDF
147. Quality of Life Beyond Five Years After Lung Cancer Resection: An Analysis of the Boston Lung Cancer Study
2026 · Quiana Guo, Alexandra Potter, et al. · Journal of Thoracic and Cardiovascular Surgery
84. Extent of Resection for STAS-positive Stage IA1-2 (≤2cm) Non-Small Cell Lung Cancer
2026 · Zhizhou Yang, Mari Mino-Kenudson, et al. · Journal of Thoracic and Cardiovascular Surgery
Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity
2026 · Zitti, Béatrice, Duval, Florent, et al. · Archive ouverte UNIGE (University of Geneva)
PDF
A zero passage ex-vivosingle cell mass response assay to predict tumor response: An observational analysis in gastrointestinal adenocarcinomas.
2025 · Bailey Mendel, Robert Kimmerling, et al. · Journal of Clinical Oncology
In vivo orientation mapping of fibrotic collagen remodeling in interstitial lung disease using polarization sensitive endobronchial optical coherence tomography
2025 · Jaeyul Lee, Sreyankar Nandy, et al.
In-vivo collagen orientation assessment to predict progression in idiopathic pulmonary fibrosis using polarization-sensitive endobronchial optical coherence tomography
2025 · Jaeyul Lee, Sreyankar Nandy, et al.
Abstract B015: Assessment of apoptotic priming in thymic epithelial tumors to define hallmarks of pathogenesis and novel therapeutic strategies
2025 · Christopher Nabel, Yin P. Hung, et al. · Cancer Research
Abstract 659: A novel manganese MRI contrast agent (PyC3A) for the evaluation of hepatic neoplasms
2018 · Derek J. Erstad, Ian Ramsay, et al. · Cancer Research
Abstract 177: Inhibition of the autotaxin-lysophosphatidic acid (ATX-LPA) pathway for chemoprevention of hepatocellular carcinoma.
2013 · Lan Wei, Yujin Hoshida, et al. · Cancer Research
Works count: 19
Citation count: 6
H-index: 1
I10-index:
Year
Topic
Type